Macrogenics (MGNX) Provides Update on Corporate Progress, TAMARACK Phase 2 Study Data, Q1 Results

Go back to Macrogenics (MGNX) Provides Update on Corporate Progress, TAMARACK Phase 2 Study Data, Q1 Results
MACROGENICS (NASDAQ: MGNX) Delayed: 4.58 --0 (-0%)
Previous Close $4.58    52 Week High $36.11 
Open $4.58    52 Week Low $14.84 
Day High $4.58    P/E 11.74 
Day Low $4.58    EPS $0.39 
Volume 6,873